Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients

Siegel, 2017, Colorectal cancer statistics, 2017, CA Cancer J Clin, 67, 177, 10.3322/caac.21395 Söreide, 2006, Microsatellite instability in colorectal cancer, Br J Surg, 93, 395, 10.1002/bjs.5328 Cancer Genome Atlas Network, 2012, Comprehensive molecular characterization of human colon and rectal cancer, Nature, 487, 330, 10.1038/nature11252 De Sousa, 2013, Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions, Nat Med, 19, 614, 10.1038/nm.3174 Guinney, 2015, The consensus molecular subtypes of colorectal cancer, Nat Med, 21, 1350, 10.1038/nm.3967 Vilar, 2010, Microsatellite instability in colorectal cancer-the stable evidence, Nat Rev Clin Oncol, 7, 153, 10.1038/nrclinonc.2009.237 Tournigand, 2004, FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study, J Clin Oncol, 22, 229, 10.1200/JCO.2004.05.113 Des Guetz, 2010, Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX, Anticancer Res, 30, 4297 Ribic, 2003, Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer, N Engl J Med, 349, 247, 10.1056/NEJMoa022289 Jover, 2006, Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer, Gut, 55, 848, 10.1136/gut.2005.073015 Raymond, 1998, Oxaliplatin: a review of preclinical and clinical studies, Ann Oncol, 9, 1053, 10.1023/A:1008213732429 Chaney, 2005, Recognition and processing of cisplatin- and oxaliplatin-DNA adducts, Crit Rev Oncol Hematol, 53, 3, 10.1016/j.critrevonc.2004.08.008 Lv, 2013, Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer, Cancer Invest, 31, 24, 10.3109/07357907.2012.716468 Zaanan, 2014, ERCC1, XRCC1 and GSTP1 single nucleotide polymorphisms and survival of patients with colon cancer receiving oxaliplatin-based adjuvant chemotherapy, J Cancer, 5, 425, 10.7150/jca.8594 Benatti, 2005, Microsatellite instability and colorectal cancer prognosis, Clin Cancer Res, 11, 8332, 10.1158/1078-0432.CCR-05-1030 Nazemalhosseini Mojarad, 2016, Low level of microsatellite instability correlates with poor clinical prognosis in stage ii colorectal cancer patients, J Oncol, 2016, 2196703 Lamberti, 2007, Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer, Int J Colorectal Dis, 22, 145, 10.1007/s00384-006-0131-8 Storojeva, 2005, Prognostic and predictive relevance of microsatellite instability in colorectal cancer, Oncol Rep, 14, 241 Phipps, 2014, Family history of colorectal cancer is not associated with colorectal cancer survival regardless of microsatellite instability status, Cancer Epidemiol Biomarkers Prev, 23, 1700, 10.1158/1055-9965.EPI-14-0533 Locker, 2006, ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer, J Clin Oncol, 24, 5313, 10.1200/JCO.2006.08.2644 Duffy, 2014, Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update, Int J Cancer, 134, 2513, 10.1002/ijc.28384 Park, 2003, ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy, Clin Adv Hematol Oncol, 1, 162 Stoehlmacher, 2001, A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer, Anticancer Res, 21, 3075